Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2020 September;45(3) > Minerva Endocrinologica 2020 September;45(3):273-5

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Minerva Endocrinologica 2020 September;45(3):273-5

DOI: 10.23736/S0391-1977.20.03122-3

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway

Shufeng CHENG 1, Liang LI 2, Chunquan SONG 3, Huijing JIN 4, Shouguo MA 5, Ping KANG 6

1 Department of Nephrology, People’s Hospital of Zhangqiu Area, Jinan, China; 2 Department of Pharmacy, Yidu Central Hospital, Weifang, China; 3 Department of Pharmacy, Qingdao Central Hospital, Qingdao, China; 4 Ward Department, People’s Hospital of Zhangqiu Area, Jinan, China; 5 Department of Burn and Plastic Surgery, People’s Hospital of Zhangqiu Area, Jinan, China; 6 Department of Rehabilitation, People’s Hospital of Zhangqiu Area, Jinan, China



top of page